11-5254409-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM2PP3

The NM_000184.3(HBG2):​c.198G>C​(p.Lys66Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as other (no stars).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

HBG2
NM_000184.3 missense

Scores

4
9
5

Clinical Significance

other no assertion criteria provided O:1

Conservation

PhyloP100: 0.508

Publications

2 publications found
Variant links:
Genes affected
HBG2 (HGNC:4832): (hemoglobin subunit gamma 2) The gamma globin genes (HBG1 and HBG2) are normally expressed in the fetal liver, spleen and bone marrow. Two gamma chains together with two alpha chains constitute fetal hemoglobin (HbF) which is normally replaced by adult hemoglobin (HbA) at birth. In some beta-thalassemias and related conditions, gamma chain production continues into adulthood. The two types of gamma chains differ at residue 136 where glycine is found in the G-gamma product (HBG2) and alanine is found in the A-gamma product (HBG1). The former is predominant at birth. The order of the genes in the beta-globin cluster is: 5'- epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]
HBG2 Gene-Disease associations (from GenCC):
  • hemoglobinopathy Toms River
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cyanosis, transient neonatal
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 4 uncertain in NM_000184.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.813

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBG2NM_000184.3 linkc.198G>C p.Lys66Asn missense_variant Exon 2 of 3 ENST00000336906.6 NP_000175.1 P69892D9YZU9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBG2ENST00000336906.6 linkc.198G>C p.Lys66Asn missense_variant Exon 2 of 3 1 NM_000184.3 ENSP00000338082.4 P69892
ENSG00000284931ENST00000642908.1 linkc.198G>C p.Lys66Asn missense_variant Exon 2 of 3 ENSP00000495346.1
ENSG00000239920ENST00000380259.7 linkn.*1501G>C non_coding_transcript_exon_variant Exon 8 of 8 5 ENSP00000369609.3 A0A2U3TZJ3
ENSG00000239920ENST00000380259.7 linkn.*1501G>C 3_prime_UTR_variant Exon 8 of 8 5 ENSP00000369609.3 A0A2U3TZJ3

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461892
Hom.:
0
Cov.:
34
AF XY:
0.00000275
AC XY:
2
AN XY:
727248
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1112010
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.250
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
31

ClinVar

Significance: other
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

HEMOGLOBIN F (CLARKE) Other:1
Aug 05, 2011
OMIM
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
BayesDel_addAF
Uncertain
0.063
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.084
.;.;T;.
Eigen
Uncertain
0.38
Eigen_PC
Benign
0.22
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.84
T;T;T;T
M_CAP
Uncertain
0.18
D
MetaRNN
Pathogenic
0.81
D;D;D;D
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
3.4
.;.;M;.
PhyloP100
0.51
PROVEAN
Uncertain
-3.9
.;.;D;.
REVEL
Uncertain
0.51
Sift
Uncertain
0.0010
.;.;D;.
Sift4G
Uncertain
0.026
.;.;D;.
Polyphen
0.87
.;.;P;.
Vest4
0.48
MutPred
0.70
Gain of catalytic residue at K66 (P = 0.0506);Gain of catalytic residue at K66 (P = 0.0506);Gain of catalytic residue at K66 (P = 0.0506);.;
MVP
0.96
ClinPred
0.98
D
GERP RS
3.1
PromoterAI
-0.0059
Neutral
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.3
Varity_R
0.72
gMVP
0.61
Mutation Taster
=27/73
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34019507; hg19: chr11-5275639; API